Last updated on February 2019

Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

Brief description of study

Phase 3 study to evaluate the safety and efficacy of treatment with RVL-1201 compared to placebo for treatment of blepharoptosis. Eligible subjects will be randomized to one of 2 treatment arms.

Clinical Study Identifier: NCT03565887

Contact Investigators or Research Sites near you

Start Over

Carol Seidenberg

Seidenberg Protzko Eye
Havre De Grace, MD United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.